Correlation Between Vertex Pharmaceuticals and Ultragenyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Ultragenyx, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Ultragenyx.

Diversification Opportunities for Vertex Pharmaceuticals and Ultragenyx

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Vertex and Ultragenyx is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Ultragenyx go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and Ultragenyx

Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 0.4 times more return on investment than Ultragenyx. However, Vertex Pharmaceuticals is 2.48 times less risky than Ultragenyx. It trades about 0.33 of its potential returns per unit of risk. Ultragenyx is currently generating about 0.11 per unit of risk. If you would invest  40,576  in Vertex Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of  3,264  from holding Vertex Pharmaceuticals or generate 8.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Vertex Pharmaceuticals  vs.  Ultragenyx

 Performance 
       Timeline  
Vertex Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vertex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Ultragenyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Vertex Pharmaceuticals and Ultragenyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vertex Pharmaceuticals and Ultragenyx

The main advantage of trading using opposite Vertex Pharmaceuticals and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.
The idea behind Vertex Pharmaceuticals and Ultragenyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stocks Directory
Find actively traded stocks across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities